• Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Log in to your Inderes Free account to see all free content on this page.
Create account

BiBBInstruments

0.50 SEK+0.81 %10.7. klo 18.29
Less than 1K followers

BIBB

Spotlight Stock Market

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
+0.81 %
-11.52 %
+27.95 %
-79.73 %
-79.09 %
-82.20 %
-80.07 %
-89.49 %
-89.81 %

BiBBInstruments operates in the medical technology sector. The company develops biopsy instruments based on its own technology platform. The technology is mainly used in specialist healthcare and surgical departments in the treatment of various forms of cancer. The products are sold as disposable instruments with a developed drilling function and are used at the diagnostic stage. The company was founded in 2013 and is headquartered in Lund.

Read more
Market cap
80.33M SEK
Turnover
130.26K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
EPS and dividend
Financial calendar
21.8.
2026

Interim report Q2'26

6.11.
2026

Interim report Q3'26

12.2.
2027

Annual report '26

All
Press releases
ShowingAll content types

Revenue and EBIT-%

Revenue K

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Regulatory press release11.07.2026 klo 19.05

Correction regarding previous press release: Missing MAR statement

BiBBInstruments
Regulatory press release09.07.2026 klo 09.55

BibbInstruments AB: BiBB signs exclusive distribution agreement with Palex Medical Spain

BiBBInstruments
Regulatory press release23.06.2026 klo 12.27

BibbInstruments AB: BiBB receives third granted EndoDrill patent in China

BiBBInstruments

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and deep analyses
Premium tools: model portfolio, screener, insider transactions
Premium columns: Guest column, expert insights
Inderes MCP - Inderes data directly into your AI tools
Create account
Regulatory press release12.06.2026 klo 17.27

BibbInstruments AB: Bulletin from the Annual General Meeting of BiBBInstruments AB

BiBBInstruments
Press release21.05.2026 klo 09.57

BibbInstruments AB: Mayo Clinic presents first clinical case with EndoDrill[®] GI in the lower GI tract at ESGE Days 2026

BiBBInstruments
Regulatory press release11.05.2026 klo 09.55

BibbInstruments AB: Notice of annual general meeting in BiBBInstruments AB

BiBBInstruments
Regulatory press release07.05.2026 klo 10.40

BibbInstruments AB: Henry Ford Health Presented Case Series with Positive Clinical Results for EndoDrill GI at DDW 2026 in Chicago

BiBBInstruments
Regulatory press release22.04.2026 klo 18.18

BibbInstruments AB: BiBBInstruments carries out a directed issue of shares to guarantors

BiBBInstruments
Regulatory press release17.04.2026 klo 16.14

BibbInstruments AB: Shareholding notification in BiBBInstruments AB (publ)

BiBBInstruments
Regulatory press release15.04.2026 klo 15.01

BibbInstruments AB: BiBBInstruments announces outcome in rights issue

BiBBInstruments
Regulatory press release01.04.2026 klo 11.51

BibbInstruments AB: BiBBInstruments receives additional subscription intentions in the ongoing rights issue

BiBBInstruments
Regulatory press release25.03.2026 klo 22.54

BibbInstruments AB: Correction: BiBBInstruments AB (publ) publishes updated information document in connection with rights issue - incorrect ISIN code for the share

BiBBInstruments
Regulatory press release24.03.2026 klo 18.34

BibbInstruments AB: BiBBInstruments AB (publ) publishes information document in connection with rights issue

BiBBInstruments
Regulatory press release19.03.2026 klo 15.32

BibbInstruments AB: BiBBInstruments resolves on the previously announced rights issue of approximately SEK 60.3 million

BiBBInstruments
Regulatory press release13.03.2026 klo 17.09

BibbInstruments AB: Communiqué from the Extraordinary General Meeting in BiBBInstruments AB held on 13 March 2026

BiBBInstruments
Regulatory press release10.02.2026 klo 17.45

BibbInstruments AB: Notice of Extraordinary General Meeting of BiBBInstruments AB (publ)

BiBBInstruments
Regulatory press release09.02.2026 klo 19.33

BibbInstruments AB: BiBBInstruments Announces the Board of Directors' Intention to Resolve on a Rights Issue of Approximately SEK 60 Million

BiBBInstruments
Press release19.12.2025 klo 11.39

BioStock: BiBBInstruments accelerates in the US – Q4 sales surge

BiBBInstruments
Regulatory press release17.12.2025 klo 12.16

BibbInstruments AB: BiBBInstruments receives additional orders for EndoDrill[®] GI from the U.S.

BiBBInstruments
Press release04.12.2025 klo 15.19

BioStock: BiBBInstruments validates clinical need during US tour

BiBBInstruments